Level of Education Modifies Asthma Mortality in Norway and Sweden. The Nordic EpiLung Study
Helena Backman,Laxmi Bhatta,Linnea Hedman,Ben Brumpton,Iida Vähätalo,Paul G Lassmann-Klee,Bright I Nwaru,Linda Ekerljung,Steinar Krokstad,Sigrid Anna Aalberg Vikjord,Anne Lindberg,Hannu Kankaanranta,Eva Rönmark,Arnulf Langhammer
DOI: https://doi.org/10.2147/jaa.s450103
2024-03-18
Journal of Asthma and Allergy
Abstract:Helena Backman, 1, &ast Laxmi Bhatta, 2, 3, &ast Linnea Hedman, 1 Ben Brumpton, 2 Iida Vähätalo, 4, 5 Paul G Lassmann-Klee, 6 Bright I Nwaru, 7 Linda Ekerljung, 7 Steinar Krokstad, 8, 9 Sigrid Anna Aalberg Vikjord, 2 Anne Lindberg, 10 Hannu Kankaanranta, 7 Eva Rönmark, 1, &ast Arnulf Langhammer 8, &ast 1 Section of Sustainable Health/ the OLIN Unit, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden; 2 K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology NTNU, Trondheim, Norway; 3 Division of Mental Health Care, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway; 4 Department of Respiratory Medicine, Seinäjoki Central Hospital, Seinäjoki, Finland; 5 Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; 6 Clinical Physiology and Nuclear Medicine Unit, Helsinki University Hospital's Diagnostic Center and University of Helsinki, Helsinki, Finland; 7 Krefting Research Centre, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; 8 HUNT Research Centre, Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Levanger, Norway; 9 Nord-Trøndelag Hospital Trust, Levanger Hospital, Levanger, Norway; 10 Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden &astThese authors contributed equally to this work Correspondence: Helena Backman, Email Background and Aim: The relationship between socioeconomic status (SES), asthma and mortality is complex and multifaceted, and it is not established if educational level modifies the association between asthma and mortality. The aim was to study the association between asthma and mortality in Sweden and Norway and to what extent educational level modifies this association. Participants and Methods: Within the Nordic EpiLung Study, > 56,000 individuals aged 30– 69 years participated in population-based surveys on asthma and associated risk factors in Sweden and Norway during 2005– 2007. Data on educational level and 10-year all-cause mortality were linked by national authorities. The fraction of mortality risk attributable to asthma was calculated, and Cox regression was used to estimate hazard ratios (HR) and 95% confidence intervals (95% CI) for mortality related to asthma, stratified by educational level. Results: In total, 5.5% of all deaths was attributed to asthma. When adjusted for potential confounders, the HR for mortality related to asthma was 1.71 (95% CI 1.52– 1.93). Those with primary level of education had higher hazard of all-cause death related to asthma than those with tertiary level (HR 1.80, 95% CI 1.48– 2.18, vs HR 1.39, 95% CI 0.99– 1.95). Conclusion: Asthma was associated with an overall 71% increased all-cause mortality and 5.5% of deaths can be attributed to asthma. Educational levels modified the risk of mortality associated with asthma, with the highest risk among those with primary education. Keywords: epidemiology, cohort, prognosis Asthma is a common and disabling disease, with an estimated cumulative prevalence of 8–10% among adults in Western Europe, including the Nordic countries. 1,2 Along with increasing asthma prevalence, a surge in asthma mortality was seen between the 1960s and 1980s. The increased mortality from asthma could later at least partly be attributed to overuse of the β 2 -agonist fenoterol. The mortality declined substantially following stricter regulations, less use, 3 and the introduction of the inhaled corticosteroid (ICS) based asthma treatment approach. 4 Today, age-standardized mortality rates for asthma are low in most parts of Europe (0.7–0.9 per 100,000 in 2019 in the Nordic countries). 5 Causes of death may be misclassified or incomplete at higher ages, 6,7 especially when asthma is one component in a multi-morbid patient. Assessment of all-cause mortality is important to capture the entire burden of this common disease. The Nordic countries are welfare states with high educational level. Despite similarities in legislation, culture and traditions, there are differences in mortality between and within these countries, partly related to socioeconomic factors. 8–10 Although respiratory d -Abstract Truncated-
immunology,allergy,respiratory system